Chevilly-Larue, France

Geneviève Estenne-Bouhtou


Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2007-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Geneviève Estenne-Bouhtou: Innovator in Therapeutic Compounds

Introduction

Geneviève Estenne-Bouhtou is a notable inventor based in Chevilly-Larue, France. He has made significant contributions to the field of therapeutic compounds, holding a total of 2 patents. His work focuses on the development of innovative compounds that exhibit therapeutic utility.

Latest Patents

Estenne-Bouhtou's latest patents include N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives, their preparation, and their application in therapy. This invention discloses and claims a compound of general formula (I) wherein A, X, and R are as described in the patent. The application of this compound spans a variety of therapeutic uses. Another patent involves N-[phenyl (piperidin-2-yl) methyl]benzamide derivatives, their preparation, and their use in therapy. This invention also discloses a compound of general formula (I) with specific substituents that demonstrate therapeutic potential.

Career Highlights

Geneviève Estenne-Bouhtou is currently associated with Sanofi-Aventis, a leading global biopharmaceutical company. His work at Sanofi-Aventis has allowed him to focus on the development of innovative therapeutic solutions.

Collaborations

Estenne-Bouhtou has collaborated with notable colleagues such as Gihad Dargazanli and Benoît Marabout. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Geneviève Estenne-Bouhtou is a prominent inventor whose work in therapeutic compounds has the potential to impact various medical applications. His contributions to the field are marked by his innovative patents and collaborations with esteemed colleagues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…